Firefly announces new Circulating microRNA Assay - now accepting beta testers!

Monday, March 3, 2014

Firefly BioWorks has developed a novel best-in-class validation platform for multiplexed detection of microRNAs from serum, plasma, and blood in a high-throughput format. This Firefly Circulating microRNA Assay works directly from purified RNA with no required preamplification or cDNA library prep, and utilizes a novel, post-hybridization amplification step - enabling both greater efficiency and decreased bias compared to currently existing methods.

The Firefly Circulating microRNA assay is now available in limited release to beta-testers only. We are actively seeking beta testers to be the first to utilize this exciting technology. We are also hard at work on a Circulating microRNA assay that works directly from crude serum and plasma. Click here for more information or to apply to take part in our beta testing program.